4AZR
Human epidermal fatty acid-binding protein (FABP5) in complex with the endocannabinoid anandamide
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | NSLS BEAMLINE X25 |
Synchrotron site | NSLS |
Beamline | X25 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2011-03-21 |
Detector | DECTRIS PILATUS 6M |
Spacegroup name | C 2 2 21 |
Unit cell lengths | 66.120, 115.150, 108.350 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 20.000 - 2.950 |
R-factor | 0.22161 |
Rwork | 0.219 |
R-free | 0.26798 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1b56 |
RMSD bond length | 0.012 |
RMSD bond angle | 1.293 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | MOLREP |
Refinement software | REFMAC (5.5.0109) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 20.000 | 3.000 |
High resolution limit [Å] | 2.950 | 2.950 |
Rmerge | 0.110 | 0.580 |
Number of reflections | 9014 | |
<I/σ(I)> | 16.1 | 3.2 |
Completeness [%] | 99.9 | 100 |
Redundancy | 6.5 | 6.4 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | 7.5 | 25% PEG 3350, 0.1 M HEPES PH 7.5. FABP INCUBATED IN A SOLUTION SATURATED WITH RESPECT TO ANANDAMIDE PRIOR TO CRYSTALLIZATION. CRYPROTECTION: 25% GLYCEROL IN MOTHER LIQUOR. |